A mouse model of HCC demonstrated that VEGFR and FGFR signaling inhibit the secretion of IFN-γ and GZMB from T-cells, significantly upregulating PD-1 expression in T-cells and PD-L1 in tumor cells [22, 24]. The gene discussed is CD274; the disease is hepatocellular carcinoma.